Literature DB >> 27905072

Communicating Uncertainty in Benefits and Harms: A Review of Patient Decision Support Interventions.

Nick Bansback1,2, Madelaine Bell3, Luke Spooner3, Alysa Pompeo3, Paul K J Han4, Mark Harrison5,6.   

Abstract

BACKGROUND: Interventions designed to help people deliberate and participate in their healthcare choices frequently describe uncertainty in potential benefits and harms. This uncertainty can be generalized to aleatory, or first-order uncertainty, represented by risk estimates, and epistemic, or second-order uncertainty, represented by imprecision in the risk estimates.
OBJECTIVES: The aim of this short communication was to review how patient decision support interventions (PDSIs) describe aleatory and epistemic uncertainty. RESEARCH
DESIGN: We reviewed PDSIs available online in five repositories and extracted all the uncertainty statements. MEASURES: A framework was developed and each statement was classified by presentation of uncertainty (aleatory and epistemic).
RESULTS: Overall, we reviewed 460 PDSIs from eight main developers, which included 8956 uncertainty statements. When describing first-order, aleatory uncertainty, almost all PDSIs included at least one qualitative statement, such as 'treatment may cause side effects'. Forty-four percent of PDSIs included at least one natural frequency, such as '2 in 100 people have side effects'. Second-order, epistemic uncertainty was also most often communicated qualitatively; notably, nearly half of all PDSIs did not communicate epistemic uncertainty at all. Few PDSIs communicated epistemic uncertainty in quantitative terms conveying imprecision, e.g. risk ranges.
CONCLUSIONS: We found considerable heterogeneity in both the extent and manner in which aleatory and epistemic uncertainties are communicated in PDSIs. This variation is predominately explained by a lack of evidence and consensus in risk communication, particularly for epistemic uncertainty. This study highlights the need for more empirical research to understand not only the outcomes of communicating uncertainty in PDSIs but also the reasons for this variation in uncertainty communication.

Entities:  

Mesh:

Year:  2017        PMID: 27905072     DOI: 10.1007/s40271-016-0210-z

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  19 in total

Review 1.  Promoting informed decisions about cancer screening in communities and healthcare systems.

Authors:  Peter Briss; Barbara Rimer; Barbara Reilley; Ralph C Coates; Nancy C Lee; Patricia Mullen; Phaedra Corso; Angela B Hutchinson; Robert Hiatt; Jon Kerner; Prethibha George; Cornelia White; Nisha Gandhi; Mona Saraiya; Rosalind Breslow; George Isham; Steven M Teutsch; Alan R Hinman; Robert Lawrence
Journal:  Am J Prev Med       Date:  2004-01       Impact factor: 5.043

2.  Representing randomness in the communication of individualized cancer risk estimates: effects on cancer risk perceptions, worry, and subjective uncertainty about risk.

Authors:  Paul K J Han; William M P Klein; Bill Killam; Tom Lehman; Holly Massett; Andrew N Freedman
Journal:  Patient Educ Couns       Date:  2011-03-05

3.  Communicating breast cancer risks to women using different formats.

Authors:  I M Lipkus; W M Klein; B K Rimer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-08       Impact factor: 4.254

Review 4.  A systematic review on communicating with patients about evidence.

Authors:  Lyndal J Trevena; Heather M Davey; Alexandra Barratt; Phyllis Butow; Patrina Caldwell
Journal:  J Eval Clin Pract       Date:  2006-02       Impact factor: 2.431

Review 5.  The design of patient decision support interventions: addressing the theory-practice gap.

Authors:  Glyn Elwyn; Mareike Stiel; Marie-Anne Durand; Jacky Boivin
Journal:  J Eval Clin Pract       Date:  2010-08-04       Impact factor: 2.431

6.  Frequency or probability? A qualitative study of risk communication formats used in health care.

Authors:  M M Schapira; A B Nattinger; C A McHorney
Journal:  Med Decis Making       Date:  2001 Nov-Dec       Impact factor: 2.583

7.  Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?

Authors:  Nick Bansback; Mark Harrison; Carlo Marra
Journal:  Med Decis Making       Date:  2015-08-24       Impact factor: 2.583

8.  Supporting shared decisions when clinical evidence is low.

Authors:  Mary C Politi; Carmen L Lewis; Dominick L Frosch
Journal:  Med Care Res Rev       Date:  2012-11-01       Impact factor: 3.929

9.  The right tool is what they need, not what we have: a taxonomy of appropriate levels of precision in patient risk communication.

Authors:  Brian J Zikmund-Fisher
Journal:  Med Care Res Rev       Date:  2012-09-06       Impact factor: 3.929

Review 10.  Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers.

Authors:  Lyndal J Trevena; Brian J Zikmund-Fisher; Adrian Edwards; Wolfgang Gaissmaier; Mirta Galesic; Paul K J Han; John King; Margaret L Lawson; Suzanne K Linder; Isaac Lipkus; Elissa Ozanne; Ellen Peters; Danielle Timmermans; Steven Woloshin
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796

View more
  5 in total

Review 1.  Communicating uncertainty in cancer prognosis: A review of web-based prognostic tools.

Authors:  Mark Harrison; Paul K J Han; Borsika Rabin; Madelaine Bell; Hannah Kay; Luke Spooner; Stuart Peacock; Nick Bansback
Journal:  Patient Educ Couns       Date:  2018-12-12

2.  Reducing complexity of patient decision aids for community-based older adults with dementia and their caregivers: multiple case study of Decision Boxes.

Authors:  Gabriel Bilodeau; Holly Witteman; France Légaré; Juliette Lafontaine-Bruneau; Philippe Voyer; Edeltraut Kröger; Marie-Claude Tremblay; Anik M C Giguere
Journal:  BMJ Open       Date:  2019-05-09       Impact factor: 2.692

3.  Stakeholder engagement in methodological research: Development of a clinical decision support tool.

Authors:  Denise H Daudelin; Robin Ruthazer; Manlik Kwong; Rebecca C Lorenzana; Daniel J Hannon; David M Kent; Timothy E McAlindon; Norma Terrin; John B Wong; Harry P Selker
Journal:  J Clin Transl Sci       Date:  2020-02-18

4.  Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty?

Authors:  D B Raphael; N S Russell; J M Immink; P G Westhoff; M C Stenfert Kroese; M R Stam; L M van Maurik; H J G D van den Bongard; J H Maduro; M G A Sattler; T van der Weijden; L J Boersma
Journal:  Breast       Date:  2020-04-06       Impact factor: 4.380

5.  Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study.

Authors:  Glen S Hazlewood; Deborah A Marshall; Claire E H Barber; Linda C Li; Cheryl Barnabe; Vivian Bykerk; Peter Tugwell; Pauline M Hull; Nick Bansback
Journal:  Patient Prefer Adherence       Date:  2020-05-18       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.